Molds - Mold Mix 4 Injection, Solution
NDC 65044-5000

10 active ingredients · Injection, Solution (percutaneous; subcutaneous)
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 65044-5000?
  4. Molds - Mold Mix 4 Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Pharmacologic Classes

Product Information

Molds - Mold Mix 4 is a BLA-approved product labeled by Jubilant Hollisterstier Llc. This medication is typically used as a allergens [cs]. It is supplied as a injection, solution for percutaneous; subcutaneous administration. This product entry covers the primary NDC 65044-5000 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
65044-5000
Proprietary Name:
Molds - Mold Mix 4
Non-Proprietary Name: [1]
Molds - Mold Mix 4
Substance Name: [2]
Alternaria Alternata; Aspergillus Fumigatus; Aspergillus Nidulans; Aspergillus Niger Var. Niger; Aspergillus Terreus; Cladosporium Cladosporioides; Penicillium Digitatum; Penicillium Expansum; Penicillium Chrysogenum Var. Chrysogenum; Clonostachys Rosea F. Rosea
NDC Directory Status:
Non-standardized Allergenic
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s): [4]
  • Percutaneous - Administration through the skin.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.

Labeler & Regulatory Data

Labeler Name: [5]
Jubilant Hollisterstier Llc
Labeler Code:
65044
Product Label ID:
97e5c6c0-7101-49b7-8ac4-9dfc60f60cc5
FDA Application Number: [6]
BLA103888
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.

Marketing Timeline

Start Marketing Date: [9]
04-19-1941
Listing Expiration Date: [11]
12-31-2027
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 65044-5000?

The NDC code 65044-5000 is assigned by the FDA to the product Molds - Mold Mix 4. This pharmaceutical product is labeled by Jubilant Hollisterstier Llc and is currently categorized as listed product. The medication is a injection, solution administered via percutaneous; subcutaneous route. In terms of distribution, this product is available in 3 different package configurations. The associated package NDC(s) include: 65044-5000-2, 65044-5000-3, 65044-5000-4. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

20,21,22,23Allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. The selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. The use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. Utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. Avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees, dog breeders, research workers, veterinarians, etc. Allergens to which a patient is extremely sensitive should not be included in treatment mixes with allergens to which there is much less sensitivity, but should be administered separately. This allows individualized and better control of dosage increases, including adjustments in dosage becoming necessary after severe reactions which may occur with the highly reactive allergen.

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • ALTERNARIA ALTERNATA (UNII: 52B29REC7H)
  • ALTERNARIA ALTERNATA (UNII: 52B29REC7H) (Active Moiety)
  • ASPERGILLUS FUMIGATUS (UNII: X88DF51T48)
  • ASPERGILLUS FUMIGATUS (UNII: X88DF51T48) (Active Moiety)
  • ASPERGILLUS NIDULANS (UNII: 242A53RB80)
  • ASPERGILLUS NIDULANS (UNII: 242A53RB80) (Active Moiety)
  • ASPERGILLUS NIGER VAR. NIGER (UNII: 9IOA40ANG6)
  • ASPERGILLUS NIGER VAR. NIGER (UNII: 9IOA40ANG6) (Active Moiety)
  • ASPERGILLUS TERREUS (UNII: QBN8K7055X)
  • ASPERGILLUS TERREUS (UNII: QBN8K7055X) (Active Moiety)
  • CLADOSPORIUM CLADOSPORIOIDES (UNII: 4ZWY20GTGO)
  • CLADOSPORIUM CLADOSPORIOIDES (UNII: 4ZWY20GTGO) (Active Moiety)
  • PENICILLIUM DIGITATUM (UNII: 1SB49SV239)
  • PENICILLIUM DIGITATUM (UNII: 1SB49SV239) (Active Moiety)
  • PENICILLIUM EXPANSUM (UNII: 1XSC3BB35Z)
  • PENICILLIUM EXPANSUM (UNII: 1XSC3BB35Z) (Active Moiety)
  • PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (UNII: 3Y1PE1GCIG)
  • PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (UNII: 3Y1PE1GCIG) (Active Moiety)
  • CLONOSTACHYS ROSEA F. ROSEA (UNII: I5F729WZ2H)
  • CLONOSTACHYS ROSEA F. ROSEA (UNII: I5F729WZ2H) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1006482 - nettle pollen extract 100 MG/ML Injectable Solution
  • RxCUI: 1006482 - Urtica dioica pollen extract 0.1 GM/ML Injectable Solution
  • RxCUI: 1006482 - Urtica dioica pollen extract 100 MG/ML Injectable Solution
  • RxCUI: 1013991 - rough cocklebur pollen extract 40000 UNT/ML Injectable Solution
  • RxCUI: 1013991 - Xanthium strumarium pollen extract 40,000 UNT/ML Injectable Solution

Which are the Pharmacologic Classes of this product?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".